Correction to: Development and external validation of multivariable risk models to predict incident and resolved neuropathic pain: a DOLORisk Dundee study (Journal of Neurology, (2023), 270, 2, (1076-1094), 10.1007/s00415-022-11478-0)

Harry L. Hébert; Abirami Veluchamy; Georgios Baskozos; Francesca Fardo; Dimitri Van Ryckeghem; Ewan R. Pearson; Lesley A. Colvin; Geert Crombez; David L.H. Bennett; Weihua Meng; Colin N.A. Palmer; Blair H. Smith

doi:10.1007/s00415-024-12721-6

Correction to: Development and external validation of multivariable risk models to predict incident and resolved neuropathic pain: a DOLORisk Dundee study (Journal of Neurology, (2023), 270, 2, (1076-1094), 10.1007/s00415-022-11478-0)

Harry L. Hébert, Abirami Veluchamy, Georgios Baskozos, Francesca Fardo, Dimitri Van Ryckeghem, Ewan R. Pearson, Lesley A. Colvin, Geert Crombez, David L.H. Bennett, Weihua Meng, Colin N.A. Palmer, Blair H. Smith

Research output: Journal Publication › Comment/debate

Abstract

In the original version of this article, the funding information section was incorrectly given as This work was supported by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633491 (DOLORisk). BHS, CNAP, DLHB, GC and WM are members of the DOLORisk consortium and are partly supported by this grant. HLH and AV are supported by DOLORisk. Generation Scotland received core support from the Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6] and the Scottish Funding Council [HR03006]. The Wellcome Trust United Kingdom Type 2 Diabetes Case–Control Collection (supporting GoDARTS) was funded by The Wellcome Trust (072960/Z/03/Z, 084726/Z/08/Z, 084727/Z/08/Z, 085475/Z/08/Z, and 085475/B/08/Z) and as part of the EU IMI-SUMMIT program. This research was also partly supported by the NIHR Oxford Health Biomedical Research Centre (NIHR203316), and by the Wellcome Trust (203139/Z/16/Z and 203139/A/16/Z). and should have read This work was supported by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633491 (DOLORisk). BHS, CNAP, DLHB, GC and WM are members of the DOLORisk consortium and are partly supported by this grant. HLH and AV are supported by DOLORisk. Generation Scotland received core support from the Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6] and the Scottish Funding Council [HR03006]. The Wellcome Trust United Kingdom Type 2 Diabetes Case–Control Collection (supporting GoDARTS) was funded by The Wellcome Trust (072960/Z/03/Z, 084726/Z/08/Z, 084727/Z/08/Z, 085475/Z/08/Z, and 085475/B/08/Z) and as part of the EU IMI-SUMMIT program. This research was also partly supported by the NIHR Oxford Health Biomedical Research Centre (NIHR203316), and by the Wellcome Trust (203139/Z/16/Z and 203139/A/16/Z). FF was supported by a European Research Council Starting Grant (ERC-2020-StG-948838).

Original language	English
Pages (from-to)	7652-7653
Number of pages	2
Journal	Journal of Neurology
Volume	271
Issue number	12
DOIs	https://doi.org/10.1007/s00415-024-12721-6
Publication status	Published - Dec 2024
Externally published	Yes

ASJC Scopus subject areas

Neurology
Clinical Neurology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00415-024-12721-6

Fingerprint

Dive into the research topics of 'Correction to: Development and external validation of multivariable risk models to predict incident and resolved neuropathic pain: a DOLORisk Dundee study (Journal of Neurology, (2023), 270, 2, (1076-1094), 10.1007/s00415-022-11478-0)'. Together they form a unique fingerprint.

Cite this

Hébert, H. L., Veluchamy, A., Baskozos, G., Fardo, F., Van Ryckeghem, D., Pearson, E. R., Colvin, L. A., Crombez, G., Bennett, D. L. H., Meng, W., Palmer, C. N. A., & Smith, B. H. (2024). Correction to: Development and external validation of multivariable risk models to predict incident and resolved neuropathic pain: a DOLORisk Dundee study (Journal of Neurology, (2023), 270, 2, (1076-1094), 10.1007/s00415-022-11478-0). Journal of Neurology, 271(12), 7652-7653. https://doi.org/10.1007/s00415-024-12721-6

Hébert, Harry L. ; Veluchamy, Abirami ; Baskozos, Georgios et al. / Correction to : Development and external validation of multivariable risk models to predict incident and resolved neuropathic pain: a DOLORisk Dundee study (Journal of Neurology, (2023), 270, 2, (1076-1094), 10.1007/s00415-022-11478-0). In: Journal of Neurology. 2024 ; Vol. 271, No. 12. pp. 7652-7653.

@article{b45c6d7ff09a4fa6a3f5160f414f5378,

title = "Correction to: Development and external validation of multivariable risk models to predict incident and resolved neuropathic pain: a DOLORisk Dundee study (Journal of Neurology, (2023), 270, 2, (1076-1094), 10.1007/s00415-022-11478-0)",

abstract = "In the original version of this article, the funding information section was incorrectly given as This work was supported by the European Union{\textquoteright}s Horizon 2020 research and innovation programme under grant agreement No 633491 (DOLORisk). BHS, CNAP, DLHB, GC and WM are members of the DOLORisk consortium and are partly supported by this grant. HLH and AV are supported by DOLORisk. Generation Scotland received core support from the Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6] and the Scottish Funding Council [HR03006]. The Wellcome Trust United Kingdom Type 2 Diabetes Case–Control Collection (supporting GoDARTS) was funded by The Wellcome Trust (072960/Z/03/Z, 084726/Z/08/Z, 084727/Z/08/Z, 085475/Z/08/Z, and 085475/B/08/Z) and as part of the EU IMI-SUMMIT program. This research was also partly supported by the NIHR Oxford Health Biomedical Research Centre (NIHR203316), and by the Wellcome Trust (203139/Z/16/Z and 203139/A/16/Z). and should have read This work was supported by the European Union{\textquoteright}s Horizon 2020 research and innovation programme under grant agreement No 633491 (DOLORisk). BHS, CNAP, DLHB, GC and WM are members of the DOLORisk consortium and are partly supported by this grant. HLH and AV are supported by DOLORisk. Generation Scotland received core support from the Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6] and the Scottish Funding Council [HR03006]. The Wellcome Trust United Kingdom Type 2 Diabetes Case–Control Collection (supporting GoDARTS) was funded by The Wellcome Trust (072960/Z/03/Z, 084726/Z/08/Z, 084727/Z/08/Z, 085475/Z/08/Z, and 085475/B/08/Z) and as part of the EU IMI-SUMMIT program. This research was also partly supported by the NIHR Oxford Health Biomedical Research Centre (NIHR203316), and by the Wellcome Trust (203139/Z/16/Z and 203139/A/16/Z). FF was supported by a European Research Council Starting Grant (ERC-2020-StG-948838).",

author = "H{\'e}bert, {Harry L.} and Abirami Veluchamy and Georgios Baskozos and Francesca Fardo and {Van Ryckeghem}, Dimitri and Pearson, {Ewan R.} and Colvin, {Lesley A.} and Geert Crombez and Bennett, {David L.H.} and Weihua Meng and Palmer, {Colin N.A.} and Smith, {Blair H.}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2024.",

year = "2024",

month = dec,

doi = "10.1007/s00415-024-12721-6",

language = "English",

volume = "271",

pages = "7652--7653",

journal = "Journal of Neurology",

issn = "0340-5354",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "12",

}

Hébert, HL, Veluchamy, A, Baskozos, G, Fardo, F, Van Ryckeghem, D, Pearson, ER, Colvin, LA, Crombez, G, Bennett, DLH, Meng, W, Palmer, CNA & Smith, BH 2024, 'Correction to: Development and external validation of multivariable risk models to predict incident and resolved neuropathic pain: a DOLORisk Dundee study (Journal of Neurology, (2023), 270, 2, (1076-1094), 10.1007/s00415-022-11478-0)', Journal of Neurology, vol. 271, no. 12, pp. 7652-7653. https://doi.org/10.1007/s00415-024-12721-6

Correction to: Development and external validation of multivariable risk models to predict incident and resolved neuropathic pain: a DOLORisk Dundee study (Journal of Neurology, (2023), 270, 2, (1076-1094), 10.1007/s00415-022-11478-0). / Hébert, Harry L.; Veluchamy, Abirami; Baskozos, Georgios et al.
In: Journal of Neurology, Vol. 271, No. 12, 12.2024, p. 7652-7653.

Research output: Journal Publication › Comment/debate

TY - JOUR

T1 - Correction to

T2 - Development and external validation of multivariable risk models to predict incident and resolved neuropathic pain: a DOLORisk Dundee study (Journal of Neurology, (2023), 270, 2, (1076-1094), 10.1007/s00415-022-11478-0)

AU - Hébert, Harry L.

AU - Veluchamy, Abirami

AU - Baskozos, Georgios

AU - Fardo, Francesca

AU - Van Ryckeghem, Dimitri

AU - Pearson, Ewan R.

AU - Colvin, Lesley A.

AU - Crombez, Geert

AU - Bennett, David L.H.

AU - Meng, Weihua

AU - Palmer, Colin N.A.

AU - Smith, Blair H.

PY - 2024/12

Y1 - 2024/12

N2 - In the original version of this article, the funding information section was incorrectly given as This work was supported by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633491 (DOLORisk). BHS, CNAP, DLHB, GC and WM are members of the DOLORisk consortium and are partly supported by this grant. HLH and AV are supported by DOLORisk. Generation Scotland received core support from the Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6] and the Scottish Funding Council [HR03006]. The Wellcome Trust United Kingdom Type 2 Diabetes Case–Control Collection (supporting GoDARTS) was funded by The Wellcome Trust (072960/Z/03/Z, 084726/Z/08/Z, 084727/Z/08/Z, 085475/Z/08/Z, and 085475/B/08/Z) and as part of the EU IMI-SUMMIT program. This research was also partly supported by the NIHR Oxford Health Biomedical Research Centre (NIHR203316), and by the Wellcome Trust (203139/Z/16/Z and 203139/A/16/Z). and should have read This work was supported by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633491 (DOLORisk). BHS, CNAP, DLHB, GC and WM are members of the DOLORisk consortium and are partly supported by this grant. HLH and AV are supported by DOLORisk. Generation Scotland received core support from the Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6] and the Scottish Funding Council [HR03006]. The Wellcome Trust United Kingdom Type 2 Diabetes Case–Control Collection (supporting GoDARTS) was funded by The Wellcome Trust (072960/Z/03/Z, 084726/Z/08/Z, 084727/Z/08/Z, 085475/Z/08/Z, and 085475/B/08/Z) and as part of the EU IMI-SUMMIT program. This research was also partly supported by the NIHR Oxford Health Biomedical Research Centre (NIHR203316), and by the Wellcome Trust (203139/Z/16/Z and 203139/A/16/Z). FF was supported by a European Research Council Starting Grant (ERC-2020-StG-948838).

AB - In the original version of this article, the funding information section was incorrectly given as This work was supported by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633491 (DOLORisk). BHS, CNAP, DLHB, GC and WM are members of the DOLORisk consortium and are partly supported by this grant. HLH and AV are supported by DOLORisk. Generation Scotland received core support from the Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6] and the Scottish Funding Council [HR03006]. The Wellcome Trust United Kingdom Type 2 Diabetes Case–Control Collection (supporting GoDARTS) was funded by The Wellcome Trust (072960/Z/03/Z, 084726/Z/08/Z, 084727/Z/08/Z, 085475/Z/08/Z, and 085475/B/08/Z) and as part of the EU IMI-SUMMIT program. This research was also partly supported by the NIHR Oxford Health Biomedical Research Centre (NIHR203316), and by the Wellcome Trust (203139/Z/16/Z and 203139/A/16/Z). and should have read This work was supported by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633491 (DOLORisk). BHS, CNAP, DLHB, GC and WM are members of the DOLORisk consortium and are partly supported by this grant. HLH and AV are supported by DOLORisk. Generation Scotland received core support from the Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6] and the Scottish Funding Council [HR03006]. The Wellcome Trust United Kingdom Type 2 Diabetes Case–Control Collection (supporting GoDARTS) was funded by The Wellcome Trust (072960/Z/03/Z, 084726/Z/08/Z, 084727/Z/08/Z, 085475/Z/08/Z, and 085475/B/08/Z) and as part of the EU IMI-SUMMIT program. This research was also partly supported by the NIHR Oxford Health Biomedical Research Centre (NIHR203316), and by the Wellcome Trust (203139/Z/16/Z and 203139/A/16/Z). FF was supported by a European Research Council Starting Grant (ERC-2020-StG-948838).

UR - http://www.scopus.com/inward/record.url?scp=85208915957&partnerID=8YFLogxK

U2 - 10.1007/s00415-024-12721-6

DO - 10.1007/s00415-024-12721-6

M3 - Comment/debate

C2 - 39535542

AN - SCOPUS:85208915957

SN - 0340-5354

VL - 271

SP - 7652

EP - 7653

JO - Journal of Neurology

JF - Journal of Neurology

IS - 12

ER -

Hébert HL, Veluchamy A, Baskozos G, Fardo F, Van Ryckeghem D, Pearson ER et al. Correction to: Development and external validation of multivariable risk models to predict incident and resolved neuropathic pain: a DOLORisk Dundee study (Journal of Neurology, (2023), 270, 2, (1076-1094), 10.1007/s00415-022-11478-0). Journal of Neurology. 2024 Dec;271(12):7652-7653. doi: 10.1007/s00415-024-12721-6

Correction to: Development and external validation of multivariable risk models to predict incident and resolved neuropathic pain: a DOLORisk Dundee study (Journal of Neurology, (2023), 270, 2, (1076-1094), 10.1007/s00415-022-11478-0)

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this